医学
心肌梗塞
缺血
病态的
时间轴
坏死
心脏病学
重症监护医学
内科学
历史
考古
作者
Emanuela Turillazzi,Cristoforo Pomara,Stefania Bello,Margherita Neri,Irene Riezzo,Vittorio Fineschi
出处
期刊:Current Vascular Pharmacology
[Bentham Science]
日期:2015-03-03
卷期号:13 (1): 6-19
被引量:23
标识
DOI:10.2174/15701611113119990008
摘要
Although a decline in the all-cause and cardiac mortality rates following myocardial infarction (MI) during the past 3 decades has been reported, MI is a major cause of death and disability worldwide. From a pathological point of view MI consists in a particular myocardial cell death due to prolonged ischemia. After the onset of myocardial ischemia, cell death is not immediate, but takes a finite period of time to develop. Once complete myocytes’ necrosis has occurred, a process leading to a healed infarction takes place. In fact, MI is a dynamic process that begins with the transition from reversible to irreversible ischemic injury and culminates in the replacement of dead myocardium by a fibrous scar. The pathobiological mechanisms underlying this process are very complex, involving an inflammatory response by several pathways, and pose a major challenge to ability to improve our knowledge. An improved understanding of the pathobiology of cardiac repair after MI and further studies of its underlying mechanisms provide avenues for the development of future strategies directed toward the identification of novel therapies. The chronologic dating of MI is of great importance both to clinical and forensic investigation, that is, the ability to create a theoretical timeline upon which either clinicians or forensic pathologists may increase their ability to estimate the time of MI. Aging of MI has very important practical implications in clinical practice since, based on the chronological dating of MI, attractive alternatives to solve therapeutic strategies in the various phases of MI are developing. Keywords: Biomolecular mechanisms, cardiac repair, cellular mechanisms, histomorphological dating, myocardial infarction, therapeutic strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI